Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 437

1.

Common differentially expressed proteins were found in mouse cleft palate models induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin and retinoic acid.

Wang C, Zhai SN, Yuan XG, Zhang DW, Jiang H, Qiu L, Fu YX.

Environ Toxicol Pharmacol. 2019 Sep 27;72:103270. doi: 10.1016/j.etap.2019.103270. [Epub ahead of print]

PMID:
31586870
2.

Tumor-reprogrammed resident T cells resist radiation to control tumors.

Arina A, Beckett M, Fernandez C, Zheng W, Pitroda S, Chmura SJ, Luke JJ, Forde M, Hou Y, Burnette B, Mauceri H, Lowy I, Sims T, Khodarev N, Fu YX, Weichselbaum RR.

Nat Commun. 2019 Sep 2;10(1):3959. doi: 10.1038/s41467-019-11906-2.

3.

Phagocytosis checkpoints as new targets for cancer immunotherapy.

Feng M, Jiang W, Kim BYS, Zhang CC, Fu YX, Weissman IL.

Nat Rev Cancer. 2019 Oct;19(10):568-586. doi: 10.1038/s41568-019-0183-z. Epub 2019 Aug 28. Review.

PMID:
31462760
4.

A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control.

Sun Z, Ren Z, Yang K, Liu Z, Cao S, Deng S, Xu L, Liang Y, Guo J, Bian Y, Xu H, Shi J, Wang F, Fu YX, Peng H.

Nat Commun. 2019 Aug 28;10(1):3874. doi: 10.1038/s41467-019-11782-w.

5.

Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity.

Liu Z, Han C, Dong C, Shen A, Hsu E, Ren Z, Lu C, Liu L, Zhang A, Timmerman C, Pu Y, Wang Y, Chen M, Qiao J, Fu YX.

Sci Immunol. 2019 Aug 9;4(38). pii: eaav6473. doi: 10.1126/sciimmunol.aav6473.

PMID:
31399492
6.

CD160 serves as a negative regulator of NKT cells in acute hepatic injury.

Kim TJ, Park G, Kim J, Lim SA, Kim J, Im K, Shin MH, Fu YX, Del Rio ML, Rodriguez-Barbosa JI, Yee C, Suh KS, Kim SJ, Ha SJ, Lee KM.

Nat Commun. 2019 Jul 22;10(1):3258. doi: 10.1038/s41467-019-10320-y.

7.

NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance.

Li X, Liu Z, Zhang A, Han C, Shen A, Jiang L, Boothman DA, Qiao J, Wang Y, Huang X, Fu YX.

Nat Commun. 2019 Jul 19;10(1):3251. doi: 10.1038/s41467-019-11238-1.

8.

Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8+ T Cell Apoptosis.

Qiao J, Liu Z, Dong C, Luan Y, Zhang A, Moore C, Fu K, Peng J, Wang Y, Ren Z, Han C, Xu T, Fu YX.

Cancer Cell. 2019 Jun 10;35(6):901-915.e4. doi: 10.1016/j.ccell.2019.05.005.

PMID:
31185213
9.

Targeting CD137 enhances the efficacy of cetuximab.

Kohrt HE, Colevas AD, Houot R, Weiskopf K, Goldstein MJ, Lund P, Mueller A, Sagiv-Barfi I, Marabelle A, Lira R, Troutner E, Richards L, Rajapaska A, Hebb J, Chester C, Waller E, Ostashko A, Weng WK, Chen L, Czerwinski D, Fu YX, Sunwoo J, Levy R.

J Clin Invest. 2019 Jun 3;129(6):2595. doi: 10.1172/JCI129689. Epub 2019 Jun 3. No abstract available.

10.

A bioactive mammalian disaccharide associated with autoimmunity activates STING-TBK1-dependent immune response.

Fermaintt CS, Sano K, Liu Z, Ishii N, Seino J, Dobbs N, Suzuki T, Fu YX, Lehrman MA, Matsuo I, Yan N.

Nat Commun. 2019 May 30;10(1):2377. doi: 10.1038/s41467-019-10319-5.

11.

[Expression of gamma-aminobutyric acid type A receptor beta3 subunit in murine cleft palate induced by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin].

Lei JQ, Qiu L, Ding XH, Fu YX, Yuan XG, Liu Y.

Zhonghua Kou Qiang Yi Xue Za Zhi. 2019 May 9;54(5):328-334. doi: 10.3760/cma.j.issn.1002-0098.2019.05.007. Chinese.

PMID:
31091566
12.

Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy.

Lu K, He C, Guo N, Chan C, Ni K, Lan G, Tang H, Pelizzari C, Fu YX, Spiotto MT, Weichselbaum RR, Lin W.

Nat Biomed Eng. 2018 Aug;2(8):600-610. doi: 10.1038/s41551-018-0203-4. Epub 2018 Mar 26.

PMID:
31015630
13.

Synthesis of MnCO₃/Multiwalled Carbon Nanotube Composite as Anode Material for Lithium-Ion Batteries.

Pei XY, Mo DC, Lyu SS, Zhang JH, Fu YX.

J Nanosci Nanotechnol. 2019 Sep 1;19(9):5743-5749. doi: 10.1166/jnn.2019.16564.

PMID:
30961733
14.

Khubchandani's procedure combined with stapled posterior rectal wall resection for rectocele.

Shao Y, Fu YX, Wang QF, Cheng ZQ, Zhang GY, Hu SY.

World J Gastroenterol. 2019 Mar 21;25(11):1421-1431. doi: 10.3748/wjg.v25.i11.1421.

15.

LKB1 orchestrates dendritic cell metabolic quiescence and anti-tumor immunity.

Wang Y, Du X, Wei J, Long L, Tan H, Guy C, Dhungana Y, Qian C, Neale G, Fu YX, Yu J, Peng J, Chi H.

Cell Res. 2019 May;29(5):391-405. doi: 10.1038/s41422-019-0157-4. Epub 2019 Mar 25.

PMID:
30911060
16.

Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma.

Espinosa-Cotton M, Rodman Iii SN, Ross KA, Jensen IJ, Sangodeyi-Miller K, McLaren AJ, Dahl RA, Gibson-Corley KN, Koch AT, Fu YX, Badovinac VP, Laux D, Narasimhan B, Simons AL.

J Immunother Cancer. 2019 Mar 19;7(1):79. doi: 10.1186/s40425-019-0550-z.

17.

The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy.

Wang GZ, Zhang L, Zhao XC, Gao SH, Qu LW, Yu H, Fang WF, Zhou YC, Liang F, Zhang C, Huang YC, Liu Z, Fu YX, Zhou GB.

Nat Commun. 2019 Mar 8;10(1):1125. doi: 10.1038/s41467-019-08887-7.

18.

Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy.

Luo M, Liu Z, Zhang X, Han C, Samandi LZ, Dong C, Sumer BD, Lea J, Fu YX, Gao J.

J Control Release. 2019 Apr 28;300:154-160. doi: 10.1016/j.jconrel.2019.02.036. Epub 2019 Mar 4.

PMID:
30844475
19.

EDACO, a derivative of myricetin, inhibits the differentiation of Gaoyou duck embryonic osteoclasts in vitro.

Fu YX, Wang YH, Tong XS, Gong Z, Sun XM, Yuan JC, Zheng TT, Li C, Niu DQ, Dai HG, Liu XF, Mao YJ, Tang BD, Xue W, Huang YJ.

Br Poult Sci. 2019 Apr;60(2):169-175. doi: 10.1080/00071668.2018.1564239. Epub 2019 Feb 18.

PMID:
30722674
20.

Phytochemical constituents of the pericarps of Illicium difengpi and their anti-inflammatory activity.

Ning DS, Fu YX, Peng LY, Tang H, Li LC, Wu XD, Huang YS, Pan ZH.

Nat Prod Res. 2018 Dec 22:1-7. doi: 10.1080/14786419.2018.1530232. [Epub ahead of print]

PMID:
30580629
21.

Targeting tumor cells with antibodies enhances anti-tumor immunity.

Sun Z, Fu YX, Peng H.

Biophys Rep. 2018;4(5):243-253. doi: 10.1007/s41048-018-0070-2. Epub 2018 Oct 29.

22.

T cell-derived lymphotoxin limits Th1 response during HSV-1 infection.

Yang K, Liang Y, Sun Z, Liu L, Liao J, Xu H, Zhu M, Fu YX, Peng H.

Sci Rep. 2018 Dec 7;8(1):17727. doi: 10.1038/s41598-018-36012-z.

23.

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance.

Liang Y, Tang H, Guo J, Qiu X, Yang Z, Ren Z, Sun Z, Bian Y, Xu L, Xu H, Shen J, Han Y, Dong H, Peng H, Fu YX.

Nat Commun. 2018 Nov 2;9(1):4586. doi: 10.1038/s41467-018-06890-y.

24.

Yersinia pseudotuberculosis Exploits CD209 Receptors for Promoting Host Dissemination and Infection.

He YX, Ye CL, Zhang P, Li Q, Park CG, Yang K, Jiang LY, Lv Y, Ying XL, Ding HH, Huang HP, Mambwe Tembo J, Li AY, Cheng B, Zhang SS, Zheng GX, Chen SY, Li W, Xia LX, Kan B, Wang X, Jing HQ, Yang RF, Peng H, Fu YX, Klena JD, Skurnik M, Chen T.

Infect Immun. 2018 Dec 19;87(1). pii: e00654-18. doi: 10.1128/IAI.00654-18. Print 2019 Jan.

25.

LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration.

Deng M, Gui X, Kim J, Xie L, Chen W, Li Z, He L, Chen Y, Chen H, Luo W, Lu Z, Xie J, Churchill H, Xu Y, Zhou Z, Wu G, Yu C, John S, Hirayasu K, Nguyen N, Liu X, Huang F, Li L, Deng H, Tang H, Sadek AH, Zhang L, Huang T, Zou Y, Chen B, Zhu H, Arase H, Xia N, Jiang Y, Collins R, You MJ, Homsi J, Unni N, Lewis C, Chen GQ, Fu YX, Liao XC, An Z, Zheng J, Zhang N, Zhang CC.

Nature. 2018 Oct;562(7728):605-609. doi: 10.1038/s41586-018-0615-z. Epub 2018 Oct 17.

26.

MicroRNA-214 functions as an oncogene in human osteosarcoma by targeting TRAF3.

Rehei AL, Zhang L, Fu YX, Mu WB, Yang DS, Liu Y, Zhou SJ, Younusi A.

Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5156-5164. doi: 10.26355/eurrev_201808_15711.

27.

Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy.

Hou Y, Liang H, Rao E, Zheng W, Huang X, Deng L, Zhang Y, Yu X, Xu M, Mauceri H, Arina A, Weichselbaum RR, Fu YX.

Immunity. 2018 Sep 18;49(3):490-503.e4. doi: 10.1016/j.immuni.2018.07.008. Epub 2018 Aug 28.

28.

Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.

Tang H, Qiu X, Timmerman C, Fu YX.

Methods Mol Biol. 2018;1845:275-286. doi: 10.1007/978-1-4939-8709-2_16.

PMID:
30141019
29.

Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion.

Liu X, Liu L, Ren Z, Yang K, Xu H, Luan Y, Fu K, Guo J, Peng H, Zhu M, Fu YX.

Cell Rep. 2018 Aug 21;24(8):2101-2111. doi: 10.1016/j.celrep.2018.07.062.

30.

Polymerase-mediated ultramutagenesis in mice produces diverse cancers with high mutational load.

Li HD, Cuevas I, Zhang M, Lu C, Alam MM, Fu YX, You MJ, Akbay EA, Zhang H, Castrillon DH.

J Clin Invest. 2018 Aug 31;128(9):4179-4191. doi: 10.1172/JCI122095. Epub 2018 Aug 20.

31.

A Critical Role of the IL-1β-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis.

Cai Y, Xue F, Quan C, Qu M, Liu N, Zhang Y, Fleming C, Hu X, Zhang HG, Weichselbaum R, Fu YX, Tieri D, Rouchka EC, Zheng J, Yan J.

J Invest Dermatol. 2019 Jan;139(1):146-156. doi: 10.1016/j.jid.2018.07.025. Epub 2018 Aug 16.

PMID:
30120937
32.

T Cell-Derived Lymphotoxin Is Essential for the Anti-Herpes Simplex Virus 1 Humoral Immune Response.

Yang K, Liang Y, Sun Z, Xue D, Xu H, Zhu M, Fu YX, Peng H.

J Virol. 2018 Jun 29;92(14). pii: e00428-18. doi: 10.1128/JVI.00428-18. Print 2018 Jul 15.

33.

[Seminal plasma anti-Müllerian hormone and inhibin B and serum inhibin B in predicting the outcome of routine IVF fertilization].

Wang YF, Wu X, Hu R, Wang FM, Jia ST, Pei LG, Wang H, Ouyang XE, Hu T, Fu YX.

Zhonghua Nan Ke Xue. 2017 Nov;23(11):991-996. Chinese.

PMID:
29738164
34.

A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice.

Choi JH, Kim KH, Roh KH, Jung H, Lee A, Lee JY, Song JY, Park SJ, Kim I, Lee WS, Seo SK, Choi IW, Fu YX, Yea SS, Park S.

Oncoimmunology. 2018 Jan 16;7(5):e1421890. doi: 10.1080/2162402X.2017.1421890. eCollection 2018.

35.

Immune Evasion in Tumor's Own Sweet Way.

Tang H, Fu YX.

Cell Metab. 2018 May 1;27(5):945-946. doi: 10.1016/j.cmet.2018.03.013. Epub 2018 Apr 5.

36.
37.

Subcritical Hopf Bifurcation and Stochastic Resonance of Electrical Activities in Neuron under Electromagnetic Induction.

Fu YX, Kang YM, Xie Y.

Front Comput Neurosci. 2018 Feb 6;12:6. doi: 10.3389/fncom.2018.00006. eCollection 2018.

38.

PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression.

Tang H, Liang Y, Anders RA, Taube JM, Qiu X, Mulgaonkar A, Liu X, Harrington SM, Guo J, Xin Y, Xiong Y, Nham K, Silvers W, Hao G, Sun X, Chen M, Hannan R, Qiao J, Dong H, Peng H, Fu YX.

J Clin Invest. 2018 Feb 1;128(2):580-588. doi: 10.1172/JCI96061. Epub 2018 Jan 16.

39.

Another way to not get eaten.

Zhang CC, Fu YX.

Nat Immunol. 2018 Jan;19(1):6-7. doi: 10.1038/s41590-017-0009-7. No abstract available.

PMID:
29242546
40.

Host STING-dependent MDSC mobilization drives extrinsic radiation resistance.

Liang H, Deng L, Hou Y, Meng X, Huang X, Rao E, Zheng W, Mauceri H, Mack M, Xu M, Fu YX, Weichselbaum RR.

Nat Commun. 2017 Nov 23;8(1):1736. doi: 10.1038/s41467-017-01566-5.

41.

Effects of polysaccharides from the base of Flammulina Velutipes stipe on growth of murine RAW264.7, B16F10 and L929 cells.

Chen GT, Fu YX, Yang WJ, Hu QH, Zhao LY.

Int J Biol Macromol. 2018 Feb;107(Pt B):2150-2156. doi: 10.1016/j.ijbiomac.2017.10.090. Epub 2017 Oct 16.

PMID:
29042281
42.

Switches in a genetic regulatory system under multiplicative non-Gaussian noise.

Chen X, Kang YM, Fu YX.

J Theor Biol. 2017 Dec 21;435:134-144. doi: 10.1016/j.jtbi.2017.09.010. Epub 2017 Sep 12.

PMID:
28916451
43.

Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling.

Xu MM, Pu Y, Han D, Shi Y, Cao X, Liang H, Chen X, Li XD, Deng L, Chen ZJ, Weichselbaum RR, Fu YX.

Immunity. 2017 Aug 15;47(2):363-373.e5. doi: 10.1016/j.immuni.2017.07.016. Epub 2017 Aug 8.

44.

Photochromism and molecular logic gate operation of a water-compatible bis-glycosyl diarylethene.

Chai X, Fu YX, James TD, Zhang J, He XP, Tian H.

Chem Commun (Camb). 2017 Aug 22;53(68):9494-9497. doi: 10.1039/c7cc04427e.

PMID:
28799597
45.

[Analysis of drug resistance of Acinetobacter baumannii in wound of children with traffic injury and its relationship with antibiotic use].

Liu S, Wang C, Fu YX.

Zhonghua Shao Shang Za Zhi. 2017 Jul 20;33(7):404-409. doi: 10.3760/cma.j.issn.1009-2587.2017.07.002. Chinese.

PMID:
28763905
46.

Twins methods quantitatively explore the genetic impact on children and adolescents brain gray matter volume.

Chen XL, Zhang XW, Hou X, Li X, Ma XS, Hu XM, Meng HQ, He Q, Zhao LS, Wang YC, Fu YX, Li T.

Sci Rep. 2017 Jul 13;7(1):5327. doi: 10.1038/s41598-017-03962-9.

47.

Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment.

Weinstein AM, Chen L, Brzana EA, Patil PR, Taylor JL, Fabian KL, Wallace CT, Jones SD, Watkins SC, Lu B, Stroncek DF, Denning TL, Fu YX, Cohen PA, Storkus WJ.

Oncoimmunology. 2017 Apr 28;6(6):e1322238. doi: 10.1080/2162402X.2017.1322238. eCollection 2017.

48.

IL-22 Upregulates Epithelial Claudin-2 to Drive Diarrhea and Enteric Pathogen Clearance.

Tsai PY, Zhang B, He WQ, Zha JM, Odenwald MA, Singh G, Tamura A, Shen L, Sailer A, Yeruva S, Kuo WT, Fu YX, Tsukita S, Turner JR.

Cell Host Microbe. 2017 Jun 14;21(6):671-681.e4. doi: 10.1016/j.chom.2017.05.009.

49.

Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammation.

Zhang Y, Kim TJ, Wroblewska JA, Tesic V, Upadhyay V, Weichselbaum RR, Tumanov AV, Tang H, Guo X, Tang H, Fu YX.

Cell Mol Immunol. 2018 Jul;15(7):697-709. doi: 10.1038/cmi.2017.25. Epub 2017 Jun 5.

50.

Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression.

Liao J, Luan Y, Ren Z, Liu X, Xue D, Xu H, Sun Z, Yang K, Peng H, Fu YX.

Cancer Immunol Res. 2017 Jul;5(7):560-570. doi: 10.1158/2326-6066.CIR-16-0221. Epub 2017 May 22.

Supplemental Content

Support Center